Full text
PDF![282](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aace/1028268/38078127e5cd/jnnpsyc00107-0082.png)
![283](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aace/1028268/6b009ac20740/jnnpsyc00107-0083.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black M., Mitchell J. R., Zimmerman H. J., Ishak K. G., Epler G. R. Isoniazid-associated hepatitis in 114 patients. Gastroenterology. 1975 Aug;69(2):289–302. [PubMed] [Google Scholar]
- McDonald W. I., Halliday A. M. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):4–9. [PubMed] [Google Scholar]
- Perry T. L., Wright J. M., Hansen S., Thomas S. M., Allan B. M., Baird P. A., Diewold P. A. A double-blind clinical trial of isoniazid in Huntington disease. Neurology. 1982 Apr;32(4):354–358. doi: 10.1212/wnl.32.4.354. [DOI] [PubMed] [Google Scholar]
- Rao K. V., Mitchison D. A., Nair N. G., Prema K., Tripathy S. P. Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid. Br Med J. 1970 Aug 29;3(5721):495–497. doi: 10.1136/bmj.3.5721.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabra A. F., Hallett M., Sudarsky L., Mullally W. Treatment of action tremor in multiple sclerosis with isoniazid. Neurology. 1982 Aug;32(8):912–913. doi: 10.1212/wnl.32.8.912. [DOI] [PubMed] [Google Scholar]